首页>
外国专利>
A TRANSDERMAL DOSAGE FORM COMPRISING BUPRENORPHINE FOR THE TREATING OF WITHDRAWAL OR ABSTINENCE SYNDROME IN A DRUG DEPENDENT OR OPIOID TOLERANT PREGNANT WOMAN
A TRANSDERMAL DOSAGE FORM COMPRISING BUPRENORPHINE FOR THE TREATING OF WITHDRAWAL OR ABSTINENCE SYNDROME IN A DRUG DEPENDENT OR OPIOID TOLERANT PREGNANT WOMAN
展开▼
机译:包含布伦啡的经皮给药剂型,用于治疗药物依赖性或阿片类药物耐受性孕妇的戒断或戒断综合症
展开▼
页面导航
摘要
著录项
相似文献
摘要
Dosage regimens of buprenorphine to treat withdrawal or abstinence syndrome in a drug dependent or opioid tolerant patient who is pregnant are described. The method includes treating withdrawal or abstinence syndrome of the patient by transdermal administration of an amount of buprenorphine effective to reduce withdrawal symptoms. For example, a first buprenorphine-containing transdermal dosage form can be administered for a first dosing period that is no more than about 5 days; a second buprenorphine-containing transdermal dosage form for a second dosing period that is no more than about 5 days, the second dosage form comprising the same or a greater dosage of buprenorphine than the first dosage form; and a third buprenorphine-containing transdermal dosage form for a third dosing period that is at least 2 days, the third dosage form comprising the same or a greater dosage of buprenorphine than the second dosage form.
展开▼